Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Johnson and Johnson
US Department of Justice
Colorcon
Healthtrust
Teva
Deloitte
Medtronic
Chinese Patent Office
Chubb

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,923,984

« Back to Dashboard

Which drugs does patent 6,923,984 protect, and when does it expire?

Patent 6,923,984 protects CARDIZEM LA and is included in one NDA.

This patent has ten patent family members in eleven countries.
Summary for Patent: 6,923,984
Title: Cushioning wax beads for making solid shaped articles
Abstract:Biologically inactive cushioning beads comprise at least one compressible cushioning component consisting essentially of a microcrystalline hydrocarbon wax or a natural wax, the said wax being at least 30% by weight of the biologically inactive cushioning beads. Such beads are useful for making solid shaped articles containing biologically active ingredients by compression.
Inventor(s): Remon; Jean Paul (Melle, BE)
Assignee: Universiteit Gent (Gent, BE)
Application Number:09/831,422
Patent Claim Types:
see list of patent claims
Composition; Compound; Use;

Drugs Protected by US Patent 6,923,984

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Valeant Intl CARDIZEM LA diltiazem hydrochloride TABLET, EXTENDED RELEASE;ORAL 021392-001 Feb 6, 2003 AB RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Valeant Intl CARDIZEM LA diltiazem hydrochloride TABLET, EXTENDED RELEASE;ORAL 021392-002 Feb 6, 2003 AB RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Valeant Intl CARDIZEM LA diltiazem hydrochloride TABLET, EXTENDED RELEASE;ORAL 021392-003 Feb 6, 2003 AB RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Valeant Intl CARDIZEM LA diltiazem hydrochloride TABLET, EXTENDED RELEASE;ORAL 021392-004 Feb 6, 2003 AB RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Valeant Intl CARDIZEM LA diltiazem hydrochloride TABLET, EXTENDED RELEASE;ORAL 021392-005 Feb 6, 2003 AB RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Valeant Intl CARDIZEM LA diltiazem hydrochloride TABLET, EXTENDED RELEASE;ORAL 021392-006 Feb 6, 2003 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,923,984

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9921933Sep 17, 1999
PCT Information
PCT FiledJuly 26, 2000PCT Application Number:PCT/EP00/07175
PCT Publication Date:March 29, 2001PCT Publication Number: WO01/21155

International Patents Family Members for US Patent 6,923,984

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan 3725474 ➤ Sign Up
Japan 2003509454 ➤ Sign Up
United Kingdom 9921933 ➤ Sign Up
Spain 2241637 ➤ Sign Up
European Patent Office 1131057 ➤ Sign Up
Denmark 1131057 ➤ Sign Up
Germany 60019550 ➤ Sign Up
Portugal 1131057 ➤ Sign Up
Canada 2348953 ➤ Sign Up
Australia 6566700 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
US Department of Justice
Farmers Insurance
Teva
Baxter
Deloitte
Cerilliant
Medtronic
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot